| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-08 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-08 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.28 | 2e-07 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-07 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-06 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-06 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-06 |